RECURRENT GENITAL HERPES SIMPLEX TYPE 2
Clinical trials for RECURRENT GENITAL HERPES SIMPLEX TYPE 2 explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GENITAL HERPES SIMPLEX TYPE 2 trials appear
Sign up with your email to follow new studies for RECURRENT GENITAL HERPES SIMPLEX TYPE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New herpes drug ABI-5366 enters early human safety trials
Disease control CompletedThis early-stage study tested a new drug called ABI-5366 in 115 people to see if it is safe and how the body handles it. Healthy volunteers received a single dose, while people with recurrent genital herpes (caused by HSV-2) received multiple doses. The goal was to measure drug l…
Matched conditions: RECURRENT GENITAL HERPES SIMPLEX TYPE 2
Phase: PHASE1 • Sponsor: Assembly Biosciences • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
New herpes drug enters early human testing
Symptom relief CompletedThis early-stage study tested a new drug called ABI-1179 in 103 people. First, healthy volunteers received a single dose to check safety. Then, people with recurrent genital herpes (caused by HSV-2) received multiple doses. The goal was to see if the drug is safe and how the body…
Matched conditions: RECURRENT GENITAL HERPES SIMPLEX TYPE 2
Phase: PHASE1 • Sponsor: Assembly Biosciences • Aim: Symptom relief
Last updated May 22, 2026 14:04 UTC